Introduction
Studies of the neuronal cytoskeleton of experimental animals have led to the identification of proteins that may provide a molecular basis for the establishment of neuron asymmetry and the life-long stability ofhighly elongated dendrites and axons (Dotti et al., 1987; Kosik and Finch, 1987; Lee et al., 1987 Lee et al., , 1988 Schlaepfer, 1987; Schmidt et al., 1987; Olmsted, 1986; Binder et al., 1985; Bernhard and Matus, 1984; Caceres et al., 1984; Dc Camilli et al., 1984; Sternbergen and Stennbergen, 1983 (Kosik and Finch, 1987) , and the different phospho-isoforms of neuronal tau (Papasozomenos et al. , 1987) .
Interest in the neunonal cytoskeleton derives partly from its strucrural and dynamic functions (Chamak et al., 1987; Hoffman et al., 1987; Weisenbeng et al, 1987) , and partly from its putative role in Alzheimer's disease (Lee et al,. 1988; Schmidt et al., 1988a Schmidt et al., , 1988b Joachim et al., 1987; Yen et al., 1987; Grundke-Iqbal et al., 1986; Kosik et al., 1984 Kosik et al., , 1986 Miller et al., 1986; Wood et al., 1986; Perry et al., 1985; Sternbenger et al., 1985) . Samples of post-mortem human CNS and PNS tissues were obtained from over 40 subjects who died with and without evidence of neurological disease. The criteria for diagnosis and the sampling procedures have been described previously (Schmidt et al., 1987 (Schmidt et al., , 1988a (Schmidt et al., , 1988b . The emphasis here was on samples that were free of neuropathology except when specifically stated. Five subjects ranged in age from 2 days to 30 years, and the remainder ranged in age from 50-94
years. An equal mix of genders was studied.
The average PMI for these samples was 12 hr with a range of3-24 hr.
Bovine and human tissues were treated in the same manner. Briefly, after immersion in fixative, tissue blocks were trimmed to 3-4-mm thick slabs at 30-60 rain intervals to facilitate penetration by 10% neutral bufl red formalin or Bouin's solution.
As compared to a number of other fixatives, Bouin's solution provides optimal preservation ofmost NF antigens (Schmidt et al., 1987; Tnojanowski et al., 1986; Hickey et al., 1983 (1987) and Schmidt et al. (1987) . Staining was evaluated as previously described (Lee et al., 1987; Schmidt et al., 1987; Trojanowski et al., 1986; Hickey et al., 1983) .
Production and Immunochemical
Characterization of Monoclonal Antibodies.
MAb were raised to bovine tau using methods similar to those used previously to generate a library of MAb to NF proteins (Lee et al., 1984 (Lee et al., , 1986 (Lee et al., , 1987 (Lee et al., , 1988 et al., 1987 , 1988a , 1988b Lee et al., 1986 Lee et al., , 1987 Lee et al., , 1988 , 1986 , 1987 , 1988 Schmidt et al., 1987) . :"
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'1' Table 1 were also applied to strips containing NF and glial filament proteins and, except for RM087, none of these MAb crossreacted with Triton X-100-insoluble cytoskeletal proteins.
Specific Observations
Bovine and Human Hippocampus. Figure 4 illustrates tau immunoreactivity in spinal cord ( Figure 4A ) and peripheral nerve ( Figures  4B and 4C) . The most consistent and intense tau staining was seen in microwave-denatured as constrasted with Bouin's-fixed tissues.
In addition, enzymatic dephosponylation of tissue sections did not alter the normal tau distribution pattern, consistent with the immunochemical data.
Studies of Tau in Human Neural Cell Lines
None of the putative neunonal and glial human cell lines studied here exhibited tau immunoreactivity, although some of these cell lines had previously been shown to express NF triplet proteins (He Ct al. , in press). Therefore, in neoplastic human cell lines the cxpression of NF triplet proteins appears to be regulated independently of the expression of tau.
Discussion
We have characterized the post-mortem stability and normal dis- rons is similar to that described in perfusion-fixed experimental animals (Olmsted, 1986; Binder et al., 1985) . Third, tau immunoreactivity in bovine hippocampus subjected to long PMIs never resembled any ofthe abnormalities seen in Alzheimer brains stained with anti-tau MAb (Joachim et al., 1987; Yen et al., 1987; Gnundke-Iqbal et al., 1986; Kosik et al., 1986; Penny et al., 1985; Kosik and Finch, 1987) . This could reflect heterogeneity among MAP in different species or brain regions owing to phosphorylation or other factors (Fischer et al., 1987; Papazosomenos and Binder, 1987) . .. .
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